AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (2.9 MB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Research Article | Open Access

Down-Regulation of fliL Gene Expression by Ag Nanoparticles and TiO2 Nanoparticles in Pragmatic Clinical Isolates of Proteus mirabilis and Proteus vulgaris from Urinary Tract Infection

Tahreer Hadi Saleh1( )Saba Talib Hashim1Salma Nassrullah Malik2Bahaa Abdullah Laftaah AL-Rubaii3
Department of Biology, College of Science, Mustansiriyah University, Baghdad, Iraq
Department of Radiotherapy, Institute of Medical Technology, Baghdad, Iraq
Department of Biology, College of Science, the University of Baghdad, Baghdad, Iraq
Show Author Information

Abstract

Ten isolates belonging to Proteus spp. were collected and obtained from Department of Biology, College of Science, the University of Baghdad. The diagnosis was done by polymerase chain reaction (PCR) technique using 16S rRNA gene and urease C gene. All isolates (100%) were sensitive to meropenem, imipenem, ciprofloxacin, gentamycin, amoxicillin, clavulanic acid and levofloxacin. These isolates also showed 60% sensitivity to cefixime and nitrofurantoin. However, both species of P. mirabilis and P. vulgaris showed the lowest sensitivity when treated with tetracycline (60%) and amikacin (20%). Cephalothin had a variable effect on the species under study as P. mirabilis isolates were 100% sensitive in comparison with the 80% sensitivity of P. vulgaris isolates. The antibacterial activities of Ag and TiO2 nanoparticles (NPs) were investigated. The minimum inhibitory concentration (MIC) value of Ag NPs against both species isolates was 10 mg/mL, while the MIC value of TiO2 NPs was 14 mg/mL against P. mirabilis and 15 mg/mL against P. vulgaris isolates. P. mirabilis isolates showed larger swarming diameter than P. vulgaris, but this motility phenomenon of P. vulgaris was arrested rapidly after incubation with sub-MIC of TiO2 NPs and Ag NPs comparatively with control. All isolates showed shifting to down-regulation in the fliL gene expression under the effect of the NPs using TiO2 NPs and Ag NPs. In conclusion, down-regulation of the fliL gene expression is directly linked to the inhibition of swarming movement of Proteus species. We encourage using these inhibitors (after tests to ensure minimal toxicity to human) in combination with antibiotics to ensure bactericidal /bacteriostatic effect to treat Proteus infections.

References

[1]

R. Belas, J. Manos, and R. Suvanasuthi, Proteus mirabilis ZapA metalloprotease degrades a broad spectrum of substrates, including antimicrobial peptides. Infect Immun. 2004, 72: 5159-5167.

[2]

V. Sosa, G. Schlapp, and P. Zunino, Proteus mirabilis isolates of different origins do not show correlation with virulence attributes and can colonize the urinary tract of mice. Microbiol. 2006, 152: 2149-2157.

[3]

S.M. Jacobsen, D.J. Stickler, H.L.T. Mobley, et al., Complicated catheter associated urinary tract infections due to Escherichia coli and Proteus mirabilis. ClinMicrobiol Rev., 2008, 21: 26-59.

[4]
K. Struble, M.S. Bronze, and G. Gonzalez, Proteus infections: Overview. eMedicine, 2009.
[5]

M.N. Abdul-Gani, B.A. Laftaah, Purification and characterization of chondroitinase ABC from Proteus vulgaris, an Iraqi clinically isolate. Curr Sci, 2017, 113(11): 2134-2140.

[6]

M.J.K. Al-Imam, B.A.L. Al-Rubaii, The influence of some amino acids, vitamins and anti-inflammatory drugs on activity of chondroitinase produced by Proteus vulgaris caused urinary tract infection. Iraqi J Sci, 2016, 57(4A): 2412-2421.

[7]

K. Bush, Alarming β-lactamase-mediated resistance in multidrug-resistant Enterobacteriaceae. Curr Opin Microbiol. 2010, 13: 558-564.

[8]

L. Chen, N. Al Laham, K.D. Chavda, et al., First report of an OXA-48-producing multidrug-resistant Proteus mirabilis strain from Gaza, Palestine. Antimicrob Agents Chemother, 2015, 59: 4305-4307.

[9]

R. Belas, The swarming phenomenon of Proteus mirabilis. Am Soc Microbiol, 1992, 58: 15-22.

[10]

D. B Kearns, R. Losick, Swarming motility in undomesticated Bacillus subtilis. Mol Microbiol, 2003, 49: 581-590.

[11]

J. Bloch, X. Lemaire, L. Legout, et al., Brain abscesses during Proteus vulgaris. Bacteremia Neurol Sci, 2010, 32: 661-663.

[12]

K. Cusick, Y.Y. Lee, B. Youchak, et al., Perturbation of fliL interferes with Proteus mirabilis swarmer cell gene expression and differentiation. J Bacteriol, 2012, 194(2): 437-447.

[13]
R.M. Macnab, Flagella and motility. Escherichia coli and Salmonella: Cellular and molecular biology. ASM Press, 1996: 123-145.
[14]

R Snigh, S. Nadhe, S. Wadhwani, et al., Nanoparticles for control of Biofilms of Acinetobacter species. Material, 2016, 9(5): 383.

[15]

G. Franci, A. Falango, S. Galdiero, et al., Silver nanoparticales as potential antibacterial agents. Molecules, 2015, 20(5): 8856-8874.

[16]

A.J. Huh, Y.J. Kwon, "Nanoantibiotics": A new paradigm for treating infectious diseases using nanomaterials in the antibiotics resistant era. J Control Release: Off. J. Controll Release Soc, 2011, 156: 128-145.

[17]

S. Zaidi, L. Misba, and A.U. Khan, Nano-therapeutics: A revolution in infection control in post antibiotic era. Nanomed Nanotechnol Biol Med, 2017, 13: 2281-2301.

[18]

S. Ahn, P. Singh, M. Jang, et al., Gold nanoflowers synthesized using Acanthopanacis cortex extract inhibit inflammatory mediators in LPS-induced RAW264.7 macrophages via NF-kappaB and AP-1 pathways. Colloids Surf B Biointerfaces, 2018, 162: 398-404.

[19]

C. Marambio-Jones, E.M.V. Hoek, A review of the antibacterial effects of silver nanomaterials and potential implications for human health and the environment. J Nanopart Res, 2010, 12: 1531-1551.

[20]

J. Wist, J. Sanabria, C. Dierolf, et al., Evaluation of photocatalytic disinfection of crude water for drinking water production. Jphotochphotobio A, 2002, 147: 241-246.

[21]

M. AlMatar, E.A. Makky, I. Var, et al., The role of nanoparticles in the inhibition of multidrug-resistant bacteria and biofilms. Curr Drug Deliv, 2017, 15: 470-484.

[22]

S. Hosseinzadeh, H. Baharifar, and A. Amani, Efficacy of a model nano-TiO2 sunscreen preparation as a function of ingredients concentration and ultrasonication treatment. Pharm Sci, 2017, 23 (2): 129-135.

[23]

S. Pavasupree, J. Jitputti, S. Ngamsinlapasathian, et al., Hydrothermal synthesis, characterization, photocatalytic activity and dye sensitized solar cell performance of mesoporous anatase TiO2 nanopowders. Mater Res Bull, 2008, 43: 149-157.

[24]
M.J.K. AL-Imam, Molecular study on chondroitinase from Proteus vulgaris caused urinary tract infection. Thesis. University of Baghdad, Iraq, 2016.
[25]
J.A. Morello, H.E. Mizer, and P.A. Granato, Laboratory manual and work book in microbiology applications to patient care, 18th ed. McGraw Hill, 2006.
[26]

J. McFarland, Nephelometer an instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines. JAMA, 1907, 14(1): 1176-1178.

[27]
Clinical and Laboratory Standards Institute (CLSI), Performance standards for antimicrobial susceptibility testing, 26th ed., 2018, M100S. Standards M02-A12, M07-A-10, and M11-A8. Wayne, Pennsylvania, USA.
[28]

S. Charannya, D. Duraivel, K. Padminee, et al., Comparative evaluation of antimicrobial efficacy of silver nanoparticles and 2% chlorhexidine gluconate when used alone and in combination assessed using agar diffusion method: An in vitro study. Contemp Clin Dent, 2018, 9: S 204-209.

[29]

B.A. Laftaah, The inhibitory and stimulatory behaviour for some of chemical compounds and watery extract of black tea and Arabian coffee on the swarming phenomenon of clinical isolates of Proteus Mirabilis. JUAPS, 2012, 6: 5-11.

[30]

K.J. Livak, T.D. Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method. Methods, 2001, 25: 402-408.

[31]

B.Q. Al-Saadi, S.J. Kadhum, and S.H. Muhaiesen, Isolation of uropathogens from pediatric associated UTI, with special focus on the detection of Proteus vulgaris. Iraqi J Biotech, 2015, 14: 77-84.

[32]

A.A. Mukhtar, N.A.A. Alfadil, M.S. Mohamed, et al., Identification of Proteus mirabilis on banknotes using 16s rRNA gene in Khartoum State. Sudan J M S, 2018, 13(3): 175-186.

[33]

M. Adnan, I.H. Aziz, and M.S. Al-Deresawi, Molecular detection of Proteus mirabilis using PCR technique among urinary tract infection patients. Iraqi J Biotech, 2014, 13(2): 35-47.

[34]

J.B. Patel, 16S rRNA gene sequencing for bacterial pathogen identification in the clinical laboratory. Mol Diagn, 2001, 6: 313-321.

[35]

J.E. Clarridge, Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin Microbiol Rev, 2004, 17(4): 840-862.

[36]

P. Tshikhudo, R. Nnzeru, K. Ntushelo, et al., Bacterial species identification getting easier. Afr. J. Biotechnol, 2013, 12(41): 5975-5982.

[37]

F. Barbut, M. Monot, A. Rousseau, et al, Rapid diagnosis of Clostridium difficile infection by multiplex real-time PCR. Eur J Clin Microbiol Infect Dis, 2011, 30: 1279-1285.

[38]
M.N. Abdul-Gani, Investigation chondroitinase from P. vulgaris and studying its effect on animal tissue. MSc thesis. Biology Department. College of sciences. Baghdad University, Iraq, 2015.
[39]
S.S.Q. Hussein, Relationship between Swarming and Biofilm in Proteus spp isolated from Urinary tract infection patients. MSc thesis. Biology Department. College of sciences. Baghdad University, Iraq, 2015.
[40]

R.Y. Pelgrift, A.J. Friedman, Nanotechnology as a therapeutic tool to combat microbial resistance. Adv Drug Deliv Rev, 2013, 65: 1803-1815.

[41]

B.A. Kadhum, S.H. Khalaf, Isolation & pathogenic study on Proteus mirabilis. J. of Baghdad for Sci, 2009, 7: 317-326.

[42]

R.D. Samsuddin, A. Sulong, N.S. CheHussin, et al., Prevalence of Proteus species with reduced susceptibility to imipenem isolated from a tertiary referral hospital in Malaysia. Malays J Microbiol, 14(6): 513-518.

[43]

A. Philippon, R. Labia, and G. Jacoby, Extended-spectrum beta-lactamases. Antimicrob Agents Chemother, 1989, 33: 1131-1136.

[44]

W. Song, J. Kim, I.K. Bae, et al., Chromosome-encoded AmpC and CTX-M extended-spectrum β-lactamases in clinical isolates of Proteus mirabilis from Korea. Antimicrob Agents Chemother, 2011, 55: 1414-1419.

[45]

D.M. Livermore, M.W. Carter, S. Bagel, et al., In vitro activities of ertapenem (MK-0826) against recent clinical bacteria collected in Europe and Australia. Antimicrob Agents Chemother, 2001, 45: 1860-1867.

[46]

P.A. Bradford, Extend-spectrum B-lactomase in the 21 century: Characterization, epidemiology, and detection of this important resistant threat. Clin Microbiol Rev, 2001, 14: 933-951.

[47]

J.A. Karlowsky, M.E. Jones, C. Thronsberry, et al., Trend in Antimicrobials susceptibilities among Enterobacteriaceae isolated from hospitalized patients in United States from 1980-2001. Antimicrob Agents Chemother, 2003, 47(5): 1672-1680.

[48]
G.F. Brooks, K.C. Carroll, J.S. Butel, et al., Adelberg's medical microbiology, 24th ed. McGraw-Hill, 2007.
[49]

I. Stock, Natural antibiotic susceptibility of Proteus spp., with special reference to P. mirabilis and P. penneri strains. J Chemother, 2003, 15: 12-26.

[50]

R.M. Mordi, M.I. Momoh, Incidence of Proteus species in wound infections and their sensitivity pattern in the University of Benin Teaching Hospital. Afr J Biotechnol, 2009, 8: 725-730.

[51]

I.O. Enabulele, S.C. Yah, E.O. Yusuf, et al., Emerging quinolones resistant transfer genes among gram-negative bacteria, isolated from faeces of HIV/AIDS patients attending some Clinics and Hospitals in the City of Benin, Edo State, Nigeria, Online J Health Allied Scs, 2006, 5(3).

[52]

K. Bush, G.A. Jacoby, and A.A. Medeiros, A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother, 1995, 39: 1211-1233.

[53]

A. Parveen, M.S. Yalagatti, V. Abbaraju, et al., Emphasized mechanistic antimicrobial study of biofunctionalized silver nanoparticles on model Proteus mirabilis. Journal of Drug Delivery, 2018, 2018: 1-10.

[54]

H.Q. Raheem, A.A. Al-Thahab, and F.G. Abd, Antibacterial activity of silver nanoparticles extracted from Proteus mirabilis and healing the wound in rabbit. Biochem Cell Arch, 2018, 18: 97-104.

[55]

J. Junevičius, J. Žilinskas, K. Česaitis, et al., Antimicrobial activity of silver and gold in toothpastes: A comparative analysis. Stomatologija, Baltic Dental and Maxillofacial Journal, 2015, 17(1): 9-12.

[56]

B. Buszewski, V. Railean-Plugaru, P. Pomastowski, et al., Antimicrobial activity of biosilver nanoparticles produced by a novel Streptacidiphilusdurhamensis strain. J Microbiol Immunol Infect, 2018, 51: 45-54.

[57]

A. Chatterjee, D. Nishanthini, N. Sandhiya, et al., Biosynthesis of titanium dioxide nanoparticles using Vigna Radiata. Asian J Pharm Clin Res, 2016, 9(4): 85-88.

[58]

N.B.A. Abdulrahman, Z. Nssaif, Antimicrobial activity of zinc oxide, titanium dioxide and silver nanoparticles against mithicillin-resistant Staphylococcus aureus isolates. Tikrit J Pure Sci, 21(3) 2016: 49-53.

[59]

S. Akhtar, I. Ali, S. Tauseef, et al., Synthesis, characterization and antibacterial activity of titanium dioxide (TiO2) nanoparticles, Fuuast J. Biol, 2016, 6(2): 141-147.

[60]

J.M. Correa, M. Mori, H.L. Sanches, et al., Silver nanoparticles in dental biomaterials. Int J Biomater, 2015, (485275)2015.

[61]

P.R. Abreu, M.C. Almeida, R.M. Bernardo, et al., Guava extract Psidiumguajava alters the labelling of blood constituents with technetium-99m, J Zhejiang Univ Sci B, 2006, 7(6): 429-435.

[62]

M. Raffi, F. Hussain, T.M. Bhatti, et al., Antibacterial characterization of silver nanoparticles against E. coli ATCC-15224. J. Mater. Sci. Technol. , 2008, 24(2): 192-196.

[63]

K.S. Santos, A.M. Barbosa, L.P. da Costa, et al., Silver nanocomposite biosynthesis: Antibacterial activity against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii. Molecules, 2016, 21(9): Article no. 1255.

[64]

M. Ahmadi, M. Adibhesami, The effect of silver nanoparticles on wounds contaminated with Pseudomonas aeroginosa in mice: An experimental study. Iran J Pharm Res, 2017, 16(2): 661-669.

[65]

J.K. Patra, K.H. Beak, Antibacterial activity and synergistic antibacterial potential of biosynthesized silver nanoparticales against food borne pathogenic bacteria along with its anticandidal and antioxidant effects. Front Microbiol, 2017, 8(54): 167.

[66]

C.Y. Chen, Y.H. Chen, P.L. Lu, et al., Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes. J MicrobiolImmunol Infect, 2012, 45: 228-236.

[67]

G. Rajakumar, A.A. Rahuman, S.M. Roopan, et al., Fungus-mediated biosynthesis and characterization of TiO2 nanoparticles and their activity against pathogenic bacteria. Spectrochim Acta Mol Biomol Spectrosc, 2012, 91: 23-29.

[68]

G. Rajakumar, A.A. Rahuman, B. Priyamvada, et al., Ecliptaprostrata leaf aqueous extract mediated synthesis of titanium dioxide nanoparticles. Mater Lett, 2012, 68: 115-117.

[69]

A. Kubacka, M. Diez, D. Rojo, et al., Understanding the antimicrobial mechanism of TiO2 based nano-composite films in a pathogenic bacterium. Sci Rep, 2014, 4: 4134-4143.

[70]

A. Besinis, T. de Peralta, R.D. Handy, The antibacterial effects of silver, titanium dioxide and silica dioxide nanoparticles compared to the dental disinfectant chlorhexidine on Streptococcus mutans using a suite of bioassays. Nanotoxicology, 2014, 8: 1-6.

[71]

Y. Li, W. Zhang, J. Niu, et al., Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano, 2012, 6(6): 5164-5173.

[72]

H.A. Foster, I.B. Ditta, S. Varghese, et al., Photocatalytic disinfection using titanium dioxide: Spectrumand mechanism of antimicrobial activity. Appl Microbiol Biotechnol, 2011, 90: 1847-1868.

[73]

K. Blecher, A. Nasir, and A. Friedman, The growing role of nanotechnology in combating infectious disease. Virulence, 2011, 2: 395-401.

[74]

K.M. Hindi, A.J. Ditto, M.J. Panzner, et al., The antimicrobial efficacy of sustained release silver-carbene complex-loaded L-tyrosine polyphosphate nanoparticles: Characterization, in vitro and in vivo studies. Biomaterials, 2009, 30: 3771-3779.

[75]

A.T.M. Saeb, K.A. Al-Rubeaan, M. Abouelhoda, et al., Genome sequencing and analysis of the first spontaneous nanosilver resistant bacterium Proteus mirabilis strain SCDR1. Antimicrob Resist Infect Control, 2017, 6(1): 119

[76]

A.R. Wattam, D. Abraham, O. Dalay, et al., PATRIC, the bacterial bioinformatics database and analysis resource. Nucleic Acids Res, 2014, 42: 581-591.

[77]

A.G. McArthur, G.D. Wright, Bioinformatics of antimicrobial resistance in the age of molecular epidemiology. Curr Opin Microbiol, 2015, 27: 45-50.

[78]

B.W. Senior, Investigation of the types and characteristics of the proteolytic enzymes formed by divers strains of Proteus species. J Med Microbiol, 1999, 48: 623-628.

[79]

M. Arunkumar, K. Suhashini, N. Mahesh, et al., Quorum quenching and antibacterial activity of silver nanoparticles synthesized from Sargassumpolyphyllum, Bangl J Pharmacol, 2014, 9: 54-59.

[80]

A. Hussain, M.F. Alajmi, M.A. Khan, et al., Biosynthesized silver nanoparticle (AgNP) from Pandanus odorifer leaf extract exhibits anti-metastasis and anti-biofilm potentials. Front Microbiol, 2019, 10: 8.

[81]

F.J. Osonga, A. Akgul, I. Yazgan, et al., Flavonoid-derived anisotropic silver nanoparticles inhibit growth and change the expression of virulence genes in Escherichia coli SM10. RSC Adv, 2018, 8: 4649-4661.

[82]

G.M. Fraser, C. Hughes, Swarming motility. Curr Opin Microbial, 1999, 2: 630-635.

[83]

R. Belas, Expression of multiple flagellin encoding genes of Proteus mirabilis. J Bacterial, 1994, 176: 7169-7181.

[84]

R.M. Morgenstein, B. Szostek and P.N. Rather, Regulation of gene expression during swarmer cell differentiation in Proteus mirabilis. FEMS Microbiol Rev, 2010, 34(5): 753-763.

[85]

V.K. Sharma, R.A. Yngardand, and Y. Lin, Silver nanoparticles: green synthesis and their antimicrobial activities. Adv Colloid Interface Sci, 2009, 145(1-2): 83-96.

[86]

U. Attmannspacher, B.E. Scharf, and R.M. Harshey, FliL is essential for swarming: motor rotation in absence of FliL fractures the flagellar rod in swarmer cells of Salmonella enterica. MolMicrobiol, 2008, 68: 328-341.

[87]

Z.H. Shehab, B.A.L. AL-Rubaii, Effect of D-mannose on gene expression of neuraminidase produced from different clinical isolates of Pseudomonas aeruginosa. Baghdad Sci J, 2019, 16(2): 291-298.

Nano Biomedicine and Engineering
Pages 321-332
Cite this article:
Saleh TH, Hashim ST, Malik SN, et al. Down-Regulation of fliL Gene Expression by Ag Nanoparticles and TiO2 Nanoparticles in Pragmatic Clinical Isolates of Proteus mirabilis and Proteus vulgaris from Urinary Tract Infection. Nano Biomedicine and Engineering, 2019, 11(4): 321-332. https://doi.org/10.5101/nbe.v11i4.p321-332

817

Views

97

Downloads

12

Crossref

31

Scopus

Altmetrics

Received: 18 August 2019
Accepted: 14 October 2019
Published: 16 October 2019
© Tahreer Hadi Saleh, Saba Talib Hashim, Salma Nassrullah Malik, and Bahaa Abdullah Laftaah AL-Rubaii.

This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Return